298 related articles for article (PubMed ID: 15878397)
1. Bovine type I collagen inhibits Raw264.7 cell proliferation through phosphoinositide 3-kinase- and mitogen-activated protein kinase-dependent down-regulation of cyclins D1, A and B1.
Cho MK; Suh SH; Lee CH; Kim SG
Biochim Biophys Acta; 2005 May; 1744(1):47-57. PubMed ID: 15878397
[TBL] [Abstract][Full Text] [Related]
2. Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways.
Gangoiti P; Granado MH; Wang SW; Kong JY; Steinbrecher UP; Gómez-Muñoz A
Cell Signal; 2008 Apr; 20(4):726-36. PubMed ID: 18234473
[TBL] [Abstract][Full Text] [Related]
3. The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases.
Tabruyn SP; Nguyen NQ; Cornet AM; Martial JA; Struman I
Mol Endocrinol; 2005 Jul; 19(7):1932-42. PubMed ID: 15746189
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of cell cycle regulation by v-Src.
Riley D; Carragher NO; Frame MC; Wyke JA
Oncogene; 2001 Sep; 20(42):5941-50. PubMed ID: 11593401
[TBL] [Abstract][Full Text] [Related]
5. Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion.
Lin VC; Woon CT; Aw SE; Guo C
Endocrinology; 2003 Dec; 144(12):5650-7. PubMed ID: 12970168
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclooxygenase-2 by bovine type I collagen in macrophages via C/EBP and CREB activation by multiple cell signaling pathways.
Cho MK; Cho YH; Lee GH; Kim SG
Biochem Pharmacol; 2004 Jun; 67(12):2239-50. PubMed ID: 15163555
[TBL] [Abstract][Full Text] [Related]
7. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
8. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
[TBL] [Abstract][Full Text] [Related]
9. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines.
Lee S; Tarn C; Wang WH; Chen S; Hullinger RL; Andrisani OM
J Biol Chem; 2002 Mar; 277(10):8730-40. PubMed ID: 11756437
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells.
Terada Y; Nakashima O; Inoshita S; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Oct; 56(4):1378-90. PubMed ID: 10504490
[TBL] [Abstract][Full Text] [Related]
12. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
13. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lü J
Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
[TBL] [Abstract][Full Text] [Related]
14. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
15. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
16. Arginine vasopressin inhibition of cyclin D1 gene expression blocks the cell cycle and cell proliferation in the mouse Y1 adrenocortical tumor cell line.
Schwindt TT; Forti FL; Juliano MA; Juliano L; Armelin HA
Biochemistry; 2003 Feb; 42(7):2116-21. PubMed ID: 12590600
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of zinc-stimulated p21(Cip/WAF1) and cyclin D1 induction by inhibition of PI3 kinase in HT-29 colorectal cancer cells.
Oh SY; Park KS; Kim JA; Choi KY
Exp Mol Med; 2002 Mar; 34(1):27-31. PubMed ID: 11989975
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells.
Frey MR; Clark JA; Bateman NW; Kazanietz MG; Black AR; Black JD
Biochem Pharmacol; 2004 May; 67(10):1873-86. PubMed ID: 15130764
[TBL] [Abstract][Full Text] [Related]
19. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
